AINewsWire Archives - Page 2 of 41

ThursdayAug 07, 2025 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS): 27% of Surveyed Business Leaders Expect $5M+ ROI from Quantum Optimization Within First Year

Survey by Wakefield Research and D-Wave shows 46% of surveyed business leaders expect $1 million to $5 million ROI from quantum optimization within the first year of adoption. 81% believe they have reached the limits of classical computing’s capabilities for optimization. 53% are planning to integrate quantum computing into their workflows, while 27% are considering it. Quantum optimization is seen as especially valuable in logistics, supply chain, manufacturing, planning and inventory, and R&D. 88% of participants said their organizations would “go above and beyond” for even a 5% improvement in optimization. A new survey released by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”),…

ThursdayAug 07, 2025 10:00 am

Water Scarcity Threatens AI Growth in the Gulf

The Gulf region is locked in a multitrillion-dollar pursuit to build global leadership in AI. Yet this ambition faces a formidable obstacle—access to water. Data centers supporting AI in Saudi Arabia, the UAE, and neighboring countries are guzzling massive volumes of water. The region is projected to need roughly 426 billion liters each year by 2030—turning water shortages into a serious limitation for tech growth. The UAE alone is expected to consume roughly 61 billion liters each year. According to the World Resources Institute, Qatar, the UAE, and Saudi Arabia are ranked among the most water-stressed nations globally. Daily water…

ThursdayAug 07, 2025 9:00 am

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment options. Japan’s high incidence of never-smoker NSCLC makes it a strategic region for the trial. LP-300 is being tested alongside standard chemotherapy agents in patients who have relapsed after tyrosine kinase inhibitor therapy. Lantern's AI-driven approach may help identify and accelerate development of therapies in underserved cancer markets. Additional trial data from Taiwan and the U.S. is expected later in Q3 2025. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has completed targeted patient…

WednesdayAug 06, 2025 12:10 pm

Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations

Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic, transcriptomic, and clinical data, to predict treatment synergy and patient response, and supported the design of Lantern’s FDA-cleared Phase 1B/2 trial in triple-negative breast cancer. A review of 221 clinical trials informed the development of the predictive algorithm. Non-PARP DDRi combinations with DNA-damaging agents showed strong outcomes in specific cancer subtypes. Lantern is evaluating licensing opportunities to commercialize the module for broader oncology use. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine…

TuesdayAug 05, 2025 10:00 am

YouTube Taps AI Tech to Regulate Teens’ Use of the Platform

YouTube has announced that it is introducing a new tool aimed at identifying users who are under 18. The move is part of a broader effort to shield younger audiences from content that might not be appropriate for their age group. The new feature uses AI to make educated guesses about a user’s age. Rather than relying solely on the birthdate tied to an account, it considers what kind of videos someone watches, the themes of those videos, and how long the account has been active. According to James Beser, YouTube’s product management director, this approach will help better identify…

TuesdayAug 05, 2025 9:45 am

AI Maverick Intel Inc. (BINP): The AI Platform That Might Just Replace Your SDR Team

AI Maverick’s next-gen platform can replicate human-like sales conversations—handling prospecting, objections, and scheduling with no SDR required Recent rollout includes adaptive language models, real-time buying signal detection, and multi-step consultative selling automation Company rebrand reflects shift from biotech to AI-led customer acquisition across sectors like healthcare, transportation, and insurance In a world where sales teams are expected to scale faster than ever, often with fewer resources, the rise of intelligent automation platforms is beginning to redefine how companies engage with prospects. For years, sales development representatives (“SDRs”) have filled the gap between marketing and revenue, conducting outreach, asking discovery questions,…

MondayAug 04, 2025 11:00 am

Safe Pro Group Inc.’s (NASDAQ: SPAI) Drone-Based AI Tech Selected for Next Year’s U.S. Army Futures Command Experiment

The company will participate in the U.S. Army’s CFWE-M 2026 modernization experiment at Fort Benning, where it will showcase its SpotlightAI(TM) platform. SpotlightAI detects explosive threats from drone imagery in near real-time. It has been trained on over 1.6 million drone images from Ukraine and has identified more than 28,000 threats to date. The company is working to integrate the system into the Army’s TAK ecosystem to deliver instant alerts to soldier-carried devices. Safe Pro leverages off-the-shelf drones combined with its patented AI to reduce the risk and time required for explosive threat detection. Safe Pro Group (NASDAQ: SPAI), an…

FridayAug 01, 2025 10:00 am

Musk Hails Samsung-Tesla AI Chips Deal

Samsung has signed a major $16.5 billion deal to produce AI chips for Tesla. Although Samsung didn’t mention Tesla by name in its official filing, Elon Musk confirmed the news on his platform, X. According to Musk, Samsung will manufacture Tesla’s upcoming AI6 chips at a newly built facility in Texas. He underscored the significance of the agreement, calling it a critical step forward for both companies. “This is a major milestone,” Musk noted in his post. While Samsung’s filing didn’t officially identify Tesla, it confirmed the agreement runs through 2033 and that the customer requested anonymity regarding specific terms. …

FridayAug 01, 2025 9:00 am

Wearable Devices Ltd. (NASDAQ: WLDS) Is ‘One to Watch’

Wearable Devices holds a first-mover advantage in AI-powered neural input wearables, with validation from CES Innovation Awards and early adoption in key markets. The company operates a dual-channel strategy that targets both consumer product sales and enterprise licensing opportunities. Strategic partnerships with Qualcomm, TCL-RayNeo(TM), and Media Exceed support the company’s efforts to scale commercialization globally. Its expanding patent portfolio includes recent U.S. approvals for gesture-based and hybrid voice control technologies, reinforcing its competitive edge. With active initiatives in XR, spatial computing, and predictive health monitoring, the company is positioned to benefit from multiple high-growth sectors. Wearable Devices (NASDAQ: WLDS) is a growth-stage…

ThursdayJul 31, 2025 10:00 am

More Job Openings for Workers with AI Skills Are Being Advertised

AI often sparks conversations about job loss, but it is also driving the creation of new roles across many industries. Recently, job opportunities connected to AI have seen a sharp rise as more companies seek talent familiar with this growing technology. A recent Brookings Institution report reveals that job listings that mention AI have been climbing steadily for over a decade. In the past 15 years, these postings have grown at an average yearly rate of almost 29%, far outpacing the general job market’s growth rate of 11%. AI use in business operations is expanding, especially in sectors like manufacturing.…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

Category: AINewsWire